Aspirin for the primary prevention of cardiovascular events: Recommendation and rationale

Alfred O. Berg, Janet D. Allan, Paul S. Frame, Charles J. Homer, Mark S. Johnson, Jonathan D. Klein, Tracy A. Lieu, Cynthia D. Murlow, C. Tracy Orleans, Jeffrey F. Peipert, Nola J. Pender, Albert L. Siu, Steven M. Teutsch, Carolyn Westhoff, Steven H. Woolf

Research output: Contribution to journalReview articlepeer-review

327 Scopus citations

Abstract

The U.S. Preventive Services Task Force strongly recommends that clinicians discuss aspirin chemoprevention with adults who are at increase risk for coronary heart disease. Discussions with patients should address both the potential benefits and harms of aspirin therapy.

Original languageEnglish
Pages (from-to)157-160
Number of pages4
JournalAnnals of Internal Medicine
Volume136
Issue number2
DOIs
StatePublished - 15 Jan 2002
Externally publishedYes

Fingerprint

Dive into the research topics of 'Aspirin for the primary prevention of cardiovascular events: Recommendation and rationale'. Together they form a unique fingerprint.

Cite this